ADC Therapeutics SA (ADCT)
Largest Insider Buys in Sector
ADCT Stock Price History Chart
ADCT Stock Performance
About ADC Therapeutics SA
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma; Phase III clinical trial in combination with rituximab to treat relapsed or refractory DLBCL in second-line transplant-ineligible patients; and Phase I clinical trial for treatment of relapsed or …
Insider Activity of ADC Therapeutics SA
Over the last 12 months, insiders at ADC Therapeutics SA have bought $2.86M and sold $278,289 worth of ADC Therapeutics SA stock.
On average, over the past 5 years, insiders at ADC Therapeutics SA have bought $2.86M and sold $278,289 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Redmile Group, LLC (10 percent owner) — $37.14M.
The last purchase of 200,000 shares for transaction amount of $609,000 was made by Redmile Group, LLC (10 percent owner) on 2024‑12‑11.
List of Insider Buy and Sell Transactions, ADC Therapeutics SA
| 2024-12-11 | 10 percent owner | 200,000 0.2806% | $3.04 | $609,000 | -10.81% | |||
| 2024-12-04 | Sale | 10 percent owner | 25,352 0.0263% | $2.07 | $52,479 | -0.24% | ||
| 2024-07-01 | 10 percent owner | 800,000 0.9607% | $2.81 | $2.25M | -19.02% | |||
| 2024-06-17 | Sale | director | 1,437 0.0018% | $2.89 | $4,153 | +4.61% | ||
| 2024-06-17 | Sale | director | 1,193 0.0015% | $2.89 | $3,448 | +4.61% | ||
| 2024-06-17 | Sale | director | 1,437 0.0018% | $2.89 | $4,153 | +4.61% | ||
| 2024-06-17 | Sale | director | 6,995 0.0086% | $2.89 | $20,216 | +4.61% | ||
| 2024-06-17 | Sale | director | 6,995 0.0086% | $2.89 | $20,216 | +4.61% | ||
| 2024-06-17 | Sale | director | 6,995 0.0086% | $2.89 | $20,216 | +4.61% | ||
| 2024-06-17 | Sale | director | 6,995 0.0086% | $2.89 | $20,216 | +4.61% | ||
| 2024-05-07 | Sale | Chief Executive Officer | 29,731 0.0569% | $4.48 | $133,195 | -36.65% | ||
| 2009-03-06 | director | 10,000 0.0118% | $2.75 | $27,500 | ||||
| 2007-06-20 | Sale | PRES & CEO | 8,000 0.065% | $19.02 | $152,160 | |||
| 2006-06-20 | director | 1,000 0.0069% | $16.14 | $16,135 | ||||
| 2006-06-07 | director | 10,000 0.0746% | $17.46 | $174,600 | ||||
| 2006-06-07 | director | 1,000 0.0075% | $17.46 | $17,460 | ||||
| 2006-06-05 | director | 15,000 0.1136% | $17.72 | $265,856 | ||||
| 2004-01-16 | Sale | director | 16,000 0.0251% | $3.67 | $58,720 |